{
    "body": "Which is the primary protein component of Lewy bodies?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23180276", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11814405", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10722726", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20551689", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24252509", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12541013", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23965852", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10327208", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18510319", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22843682", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24058647", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26667592", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23344955", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18607609", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10764738", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11440819", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23557146", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22516611", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9726379", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16452621", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24392030", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26502720", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10825478", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17899395", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11900526", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19475665", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12722831", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18508479", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10762166", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20617407", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26401513", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11085897", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23796501", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12122208", 
        "http://www.ncbi.nlm.nih.gov/pubmed/14502650", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16319716", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24586691", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9600990", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22483285", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26161848", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25846226", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11816795", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11207422", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16343531", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20890676"
    ], 
    "ideal_answer": [
        "The primary protein component of Lewy bodies are fibrils composed of alpha-synuclein."
    ], 
    "exact_answer": [
        "alpha-synuclein", 
        "\u03b1-synuclein", 
        "\u03b1Syn"
    ], 
    "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016631", 
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051844"
    ], 
    "type": "factoid", 
    "id": "58a2e5f760087bc10a000007", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 222, 
            "text": "Aggregation of \u03b1-synuclein (\u03b1Syn), the primary protein component in Lewy body inclusions of patients with Parkinson's disease, arises when the normally soluble intrinsically disordered protein converts to amyloid fibrils. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24058647", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 245, 
            "offsetInEndSection": 500, 
            "text": "The primary structural component of Lewy bodies are fibrils composed primarily of alpha-synuclein, a highly conserved 140 amino acid protein that is predominantly expressed in neurons and which may play a role in synaptic plasticity and neurotransmission.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22483285", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 116, 
            "text": "Fibrillar \u03b1-synuclein (AS) is the major component of Lewy bodies, the pathological hallmark of Parkinson's disease. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22516611", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 116, 
            "text": "Alpha-synuclein (alphaS) is the primary component of Lewy bodies, the pathological hallmark of Parkinson's Disease. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19475665", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 578, 
            "offsetInEndSection": 827, 
            "text": "For alpha-synuclein, the major protein component of Lewy bodies associated with Parkinson's disease, we have used a combination of ssNMR and biochemical data to identify the key region for self-aggregation of the protein as residues 77-82 (VAQKTV). ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18510319", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 134, 
            "text": "The protein alpha-synuclein (AS) is the primary fibrillar component of Lewy bodies, the pathological hallmark of Parkinson's disease. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17899395", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 159, 
            "offsetInEndSection": 276, 
            "text": "Recently, the presynaptic protein alpha-synuclein was shown to be a major component of Lewy bodies and Lewy neurites.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10327208", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 176, 
            "text": "Alpha-synuclein forms the major component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9726379", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 149, 
            "text": "\u00e1-Synuclein is the major protein component of Lewy bodies--the pathological hallmark of Parkinson's disease (PD) and Dementia with Lewy bodies (DLB).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20617407", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 135, 
            "text": "alpha-Synuclein and ubiquitin are two Lewy body protein components that may play antagonistic roles in the pathogenesis of Lewy bodies.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11085897", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 926, 
            "offsetInEndSection": 1089, 
            "text": "The segregation of alpha-synuclein to Lewy body peripheral domain is consistent with the hypothesis that alpha-synuclein is continually deposited onto Lewy bodies.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11085897", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 179, 
            "text": "Identification of protein interfaces between \u03b1-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22843682", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 374, 
            "offsetInEndSection": 634, 
            "text": "Whereas approximately 550 proteins were identified in the LB-enriched sample by mass spectrometry, quantitative comparison with the control sample revealed that approximately 40 proteins were co-enriched with alpha-synuclein, the major component in Lewy bodies", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18508479", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 509, 
            "offsetInEndSection": 1085, 
            "text": "This apparent conflict in protein levels might have arisen from examining Lewy body disease cases with coexisting Alzheimer-type pathologies.To assess whether ATP13A2 levels in Lewy body disease are modified by Alzheimer-type \u03b2-amyloid deposition, we evaluated cases of pure PD and pure dementia with Lewy bodies (DLB) for changes in ATP13A2, \u03b1-synuclein and \u03b2-amyloid protein levels in cortical regions with and without Lewy bodies.In all Lewy body disease cases, we identified decreased ATP13A2 protein levels that correlated with increases in both \u03b1-synuclein and \u03b2-amyloid", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24252509", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1087, 
            "offsetInEndSection": 1444, 
            "text": "Partial colocalization was observed between ATP13A2 and \u03b1-synuclein in Lewy bodies, whereas ATP13A2 did not colocalize with pathological \u03b2-amyloid deposition.Our data show that patients with Lewy body diseases have an overall deficit in ATP13A2 protein levels, with the remaining protein being more insoluble and partially redistributing towards Lewy bodies", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24252509", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 180, 
            "text": "Identification of protein interfaces between \u03b1-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22843682", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 175, 
            "text": "Human \u03b1-synuclein is a small-sized, natively unfolded protein that in fibrillar form is the primary component of Lewy bodies, the pathological hallmark of Parkinson's disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23557146", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 308, 
            "text": "Parkinson's disease is the most common neurodegenerative movement disorder. \u03b1-Synuclein is a small synaptic protein that has been linked to familial Parkinson's disease (PD) and is also the primary component of Lewy bodies, the hallmark neuropathology found in the brain of sporadic and familial PD patients.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20890676", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 133, 
            "text": "The protein alpha-synuclein (AS) is the primary fibrillar component of Lewy bodies, the pathological hallmark of Parkinson's disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17899395", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 107, 
            "text": "\u03b1-Synuclein is an abundant presynaptic protein and a primary component of Lewy bodies in Parkinson disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23344955", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 134, 
            "text": "The natively disordered protein alpha-synuclein is the primary component of Lewy bodies, the cellular hallmark of Parkinson's disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16343531", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 301, 
            "text": "Common cellular and molecular mechanisms including protein aggregation and inclusion body formation are involved in many neurodegenerative diseases. \u03b1-Synuclein is a major component of Lewy bodies in Parkinson's disease (PD) as well as in glial cytoplasmic inclusions in multiple system atrophy (MSA).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23965852", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 127, 
            "text": "Alpha-synuclein (\u03b1-Syn) is the principal protein component of Lewy bodies, a pathological hallmark of Parkinson's disease (PD).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23796501", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 276, 
            "text": "Lewy bodies and coarse Lewy neurites are the pathological hallmarks of degenerating neurons in the brains of patients suffering from Parkinson's disease (PD). Recently, the presynaptic protein alpha-synuclein was shown to be a major component of Lewy bodies and Lewy neurites.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10327208", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 433, 
            "text": "Lewy bodies and coarse Lewy neurites are the pathological hallmarks of degenerating neurons in the brains of patients suffering from Parkinson's disease (PD). Recently, the presynaptic protein alpha-synuclein was shown to be a major component of Lewy bodies and Lewy neurites. This study demonstrates for the first time that extensive and thin alpha-synuclein-immunoreactive inclusions are present in the axonal processes of neurons.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10327208", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 249, 
            "text": "\u00e1-Synuclein is the major protein component of Lewy bodies--the pathological hallmark of Parkinson's disease (PD) and Dementia with Lewy bodies (DLB). Its accumulation into intracellular aggregates is implicated in the process of Lewy body formation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20617407", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 123, 
            "text": "Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9726379", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 199, 
            "offsetInEndSection": 330, 
            "text": "Lewy bodies comprise of aggregated intracellular vesicles and proteins and \u03b1-synuclein is reported to be a major protein component.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26667592", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 110, 
            "text": "Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10764738", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1267, 
            "offsetInEndSection": 1384, 
            "text": "These findings indicate that alpha-synuclein forms the major filamentous component of Lewy bodies and Lewy neurites..", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9600990", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1180, 
            "offsetInEndSection": 1405, 
            "text": "The protein alpha-synuclein appears to be an important structural component of Lewy bodies, an observation spurred by the discovery of point mutations in the alpha-synuclein gene linked to rare cases of autosomal dominant PD.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11816795", 
            "endSection": "abstract"
        }
    ]
}